EUVIMEDEUVIMED entdecken
Crossref

Methionine‐PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans

Kazufumi Ohmura iD, Yuka Ikegame, Hirohito Yano, Jun Shinoda, Toru Iwama

Journal of Neuroimaging · 2023

DOI: 10.1111/jon.13126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroimaging, 2023. Verfasst von Kazufumi Ohmura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Gifu, Japan. Hauptthemen laut MEDLINE: Methionine, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose 11 C‐Methionine (MET)‐PET is a useful tool in neuro‐oncology. This study aimed to examine whether a combination of diagnostic variables associated with MET uptake could help distinguish between brain lesions that are often difficult to discriminate in conventional CT and MRI.

Methods

MET‐PET was assessed in 129 patients with glioblastoma multiforme, primary central nervous lymphoma, metastatic brain tumor, tumefactive multiple sclerosis, or radiation necrosis. The accuracy of the differential diagnosis was analyzed using five diagnostic characteristics in combination: higher maximum standardized uptake value (SUV) of MET in the lesion/the mean normal cortical SUV of MET ratio, overextension beyond gadolinium, peripheral pattern indicating abundant MET accumulation in the peripheral region, central pattern denoting abundant MET accumulation in the central region, and dynamic‐up suggesting increased MET accumulation during dynamic study. The analysis was conducted on sets of two of the five brain lesions.

Results

Significant differences in the five diagnostic traits were observed among the five brain lesions, and differential diagnosis could be achieved by combining these diagnostic features. The area under the curve between each set of two of the five brain lesions using MET‐PET features ranged from .85 to 1.0.

Conclusions

According to the findings, combining the five diagnostic criteria could help with the differential diagnosis of the five brain lesions. MET‐PET is an auxiliary diagnostic technique that could help in distinguishing these five brain lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethionineBrain NeoplasmsHumansPositron-Emission TomographyRacemethionineMagnetic Resonance ImagingBrainTomography, X-Ray ComputedRadiopharmaceuticals

Stichwörter der Autor:innen

11C-methionine-PETglioblastomametastatic brain tumorprimary central nervous lymphomaradiation necrosistumefactive multiple sclerosis

Substanzen

MethionineRacemethionineRadiopharmaceuticals

Autor:innen und Institutionen

  • Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Gifu, Japan.
  • Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Department of Clinical Brain Sciences, Gifu University Graduate School of Medicine, Gifu, Japan.

ORCID-Profile: Kazufumi Ohmura

Zitieren

APA

Ohmura, K., Ikegame, Y., Yano, H., Shinoda, J., & Iwama, T. (2023). Methionine‐PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans. Journal of Neuroimaging. https://doi.org/10.1111/jon.13126

Vancouver

Ohmura K, Ikegame Y, Yano H, Shinoda J, Iwama T. Methionine‐PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans. Journal of Neuroimaging. 2023. doi:10.1111/jon.13126

BibTeX
@article{Ohmura2023,
  author = {Ohmura, Kazufumi and Ikegame, Yuka and Yano, Hirohito and Shinoda, Jun and Iwama, Toru},
  title = {Methionine‐PET to differentiate between brain lesions appearing similar on conventional CT/MRI scans},
  journal = {Journal of Neuroimaging},
  year = {2023},
  doi = {10.1111/jon.13126}
}
Kostenlos starten →